Literature DB >> 6939690

Natural killing of tumor cells by human peripheral blood cells. Suppression of killing in vitro by tumor-promoting phorbol diesters.

W E Seaman, T D Gindhart, M A Blackman, B Dalal, N Talal, Z Werb.   

Abstract

Tumor-promoting phorbol diesters were shown to suppress natural killing in vitro by human peripheral blood mononuclear cells. The inhibitory effect of different phorbol diesters and their analogues correlated with their potency as tumor promoters, the most effective agent being 12-O-tetradecanoylphorbol-13-acetate (TPA). Both peripheral blood cells and targets specifically bound TPA, and natural killing could be inhibited by pretreatment of either cell population with TPA, though this was less effective than direct addition of TPA to the assay. Cells that had been pretreated with TPA released TPA and metabolites of tPA during subsequent incubation in fresh medium. This release of tPA was evidently responsible for the inhibition of natural killing by pretreated target cells; in experiments where labeled and unlabeled target cells were mixed, pretreatment of unlabeled targets with TPA inhibited killing of labeled targets. Suppression of natural killing by TPA was greatly reduced when adherent cells were removed from the peripheral blood cells, suggesting that monocytes mediate suppression. Inhibition of natural killing by TPA provides a model for examining the regulation of natural killing. Suppression of natural killing by phorbol diesters may contribute to their activity as tumor promoters.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6939690      PMCID: PMC370699          DOI: 10.1172/jci110161

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.

Authors:  D Santoli; H Koprowski
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

3.  Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.

Authors:  G Rovera; T G O'Brien; L Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

Review 4.  Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.

Authors:  E Saksela; T Timonen; A Ranki; P Häyry
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

5.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

6.  beta-Estradiol reduces natural killer cells in mice.

Authors:  W E Seaman; M A Blackman; T D Gindhart; J R Roubinian; J M Loeb; N Talal
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

Review 7.  Environmental carcinogenesis: an integrative model.

Authors:  J E Trosko; C C Chang
Journal:  Q Rev Biol       Date:  1978-06       Impact factor: 4.875

Review 8.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

9.  Metabolism of tritium-labeled 12-O-tetradecanoylphorbol-13-acetate by cells in culture.

Authors:  T G O'Brien; L Diamond
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

10.  Purification of human monocytes on microexudate-coated surfaces.

Authors:  S K Ackerman; S D Douglas
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

View more
  8 in total

1.  Phorbol ester treated chronic B lymphocytic leukaemia cells induce autologous T cell proliferation without generation of cytotoxic T cells.

Authors:  D Kabelitz; T H Tötterman; K Nilsson; M Gidlund
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

2.  Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.

Authors:  Anne Clavreul; Manuel Delhaye; Eric Jadaud; Philippe Menei
Journal:  J Neurooncol       Date:  2006-03-31       Impact factor: 4.130

3.  Phorbol ester regulation of Ca2+ flux during natural, lectin and antibody-dependent killing.

Authors:  M Jondal; J Ng; M Patarroyo; P A Broliden
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

4.  Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

Authors:  B Combe; R M Pope; M Fischbach; B Darnell; S Baron; N Talal
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

5.  Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.

Authors:  W E Seaman; T D Gindhart; M A Blackman; B Dalal; N Talal; Z Werb
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Mitogenic activity of 12-O-tetradecanoyl phorbol-13-acetate on peripheral blood lymphocytes from young and aged adults.

Authors:  J E Nagel; F J Chrest; W H Adler
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

7.  The effects of the anti-tumor agent mezerein on the cytotoxic capacity and oxidative metabolism of human blood cells.

Authors:  K Barton; G Randall; A L Sagone
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

8.  Collagenase is a major gene product of induced rabbit synovial fibroblasts.

Authors:  J Aggeler; S M Frisch; Z Werb
Journal:  J Cell Biol       Date:  1984-05       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.